The purpose of this study is to collect information about treatment patterns, effects, and outcomes in patients with migraines who are switching or initiating a pharmacologic treatment for migraine prevention. This is an observational study which means there will be no treatment added or taken away.
Inclusion Criteria
- A diagnosis of migraine, with or without aura, or chronic migraine, as determined by the study investigator (per International Headache Society International Classification of Headache Disorders 3rd edition guidelines)
- Switching or initiating a new pharmacologic migraine preventive treatment
- Note that:
- The initiating treatment cannot be one that has been taken in the prior 12 months.
- Concurrent migraine preventive treatment, including pharmacological, nonpharmacological, and any over-the-counter supplement taken specifically for migraine prevention, is allowed, provided the existing treatment(s) has (have) been at a stable dose for at least 3 months prior to entry. For nonpharmacological treatment, the regimen must have been stable for at least 3 months prior to entry
- Able to reliably report on historical details regarding frequency of monthly migraine headache days during the past month
Exclusion Criteria
- Are investigator site personnel directly affiliated with the study and/or their immediate families.
- Are terminally ill.
- Are participating in another study that includes treatment with an investigational drug and/or intervention at the same time as enrollment in the current study
Study Requirements
Your participation in the study will be either a single-day assessment or it will last 2 years. This depends on which preventive migraine medication you are prescribed as part of your routine care.
You will be asked to complete short questionnaires lasting 1-5 minutes each. If you qualify for the stage of the study that lasts 2 years, you will be asked to keep an electronic subject headache diary that you will be encouraged to fill out every time you experience a headache. You will fill out additional questionnaires due every 3 months or less often.
